SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • August 14th, 2007 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of July 24, 2007 (the “Effective Date”) is entered into by and between Joseph K. Belanoff, M.D., Chief Executive Officer, (“Executive”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • August 14th, 2007 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of July 24, 2007 (the “Effective Date”) is entered into by and between James N. Wilson, Chairman of the Board of Directors, (“Executive”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
